Somogy Megyei Kaposi Mor Oktato Korhaz
About Somogy Megyei Kaposi Mor Oktato Korhaz
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
11
Somogy Megyei Kaposi Mór Teaching Hospital
9
Celgene
8
Bayer
4
Hoffmann-La Roche
4
Incyte Corporation
4
Janssen Research & Development, LLC
4
Amgen
3
Astex Pharmaceuticals, Inc.
3
CTI BioPharma
3
CymaBay Therapeutics, Inc.
3
Clinical Trials at Somogy Megyei Kaposi Mor Oktato Korhaz
During the past decade, Somogy Megyei Kaposi Mor Oktato Korhaz conducted 75 clinical trials. In the 10-year time frame, 75 clinical trials started and 39 clinical trials were completed, i.e. on
average, 52% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 21 clinical trials were completed. i.e. 110.5%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Comparison of Voriconazole and Amphotericin B in Treating Patients With Aspergillosis
1997-06-01
Completed
212
Chlorambucil in Treating Patients With Advanced Chronic Lymphocytic Leukemia
2001-03-01
Unknown status
Ultraviolet Light Therapy Using Methoxsalen With or Without Bexarotene in Treating Patients With Mycosis Fungoides
2003-01-01
2011-06-01
Terminated
93
A Randomized Phase IIb Placebo-Controlled Study of R-ICE Chemotherapy With and Without SGN-40 for Patients With DLBCL
2007-09-01
2011-05-01
Terminated
151
A Study to Determine the Efficacy and Safety of Lenalidomide in Patients With Mantle Cell NHL Who Have Relapsed or Progressed After Treatment With Bortezomib or Are Refractory to Bortezomib. The "EMERGE" Trial
2008-12-22
2017-11-08
Completed
134
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
2009-01-27
2020-10-27
Completed
317
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
2009-10-13
2018-05-09
Completed
450
Investigation of Cogane (PYM50028) in Early-stage Parkinson's Disease (CONFIDENT-PD)
2010-11-01
2012-12-01
Completed
425
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Somogy Megyei Kaposi Mor Oktato Korhaz" #1 sponsor was "Pfizer" with 11 trials, followed by "Somogy Megyei Kaposi Mór Teaching Hospital" with 9 trials
sponsored, "Celgene" with 8 trials sponsored, "Bayer" with 4 trials sponsored and "Hoffmann-La Roche"
with 4 trials sponsored. Other sponsors include 61 different institutions and
companies that sponsored additional 45 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Somogy Megyei Kaposi Mor Oktato Korhaz"
#1 collaborator was "AbbVie" with 3 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "Pharma Patent Kft." with 2 trials as a collaborator and "University Medical Center Groningen" with 2 trials as a collaborator. Other collaborators include 18 different institutions and companies that were
collaborators in the rest 28 trials.
Clinical Trials Conditions at Somogy Megyei Kaposi Mor Oktato Korhaz
According to Clinical.Site data, the most researched conditions in "Somogy Megyei Kaposi Mor Oktato Korhaz" are
"Primary Myelofibrosis" (6 trials), "Acute Myeloid Leukemia" (4 trials), "Parkinson Disease" (4 trials), "Multiple Myeloma" (3 trials) and "Myelofibrosis" (3 trials). Many other conditions were trialed in "Somogy Megyei Kaposi Mor Oktato Korhaz" in a lesser frequency.
Clinical Trials Intervention Types at Somogy Megyei Kaposi Mor Oktato Korhaz
Most popular intervention types in "Somogy Megyei Kaposi Mor Oktato Korhaz" are "Drug" (86 trials), "Other" (13 trials), "Biological" (5 trials), "Procedure" (5 trials) and "Behavioral" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (31 trials), "Lenalidomide" (5 trials), "Pembrolizumab" (4 trials), "Rituximab" (4 trials) and "placebo" (4 trials). Other intervention names were less common.
Clinical Trials Genders at Somogy Megyei Kaposi Mor Oktato Korhaz
The vast majority of trials in "Somogy Megyei Kaposi Mor Oktato Korhaz" are
101 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Somogy Megyei Kaposi Mor Oktato Korhaz
Currently, there are NaN active trials in "Somogy Megyei Kaposi Mor Oktato Korhaz".
undefined are not yet recruiting,
20 are recruiting,
19 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 43 completed trials in Somogy Megyei Kaposi Mor Oktato Korhaz,
1 suspended trials,
and 15 terminated clinical trials to date.
Out of the total trials that were conducted in Somogy Megyei Kaposi Mor Oktato Korhaz, 3 "Phase 1"
clinical trials were conducted, 21 "Phase 2" clinical
trials and 67 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 4 trials, and there were
also 11 trials that are defined as “Not Applicable".